rxstat › Shortages › Atropine
Atropine shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Atropine products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Nov 1, 2020
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageATROPINE
1% · SOLUTION
SOLUTION · PHARMA STULLN INC.
DIN 02023695 · since Nov 1, 2020, no end estimate · Delay in shipping of the drug.
ResolvedATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Aug 18, 2025 · Disruption of the manufacture of the drug.
DiscontinuedATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154
ResolvedATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Aug 15, 2024 · Disruption of the manufacture of the drug.
ResolvedATROPINE INJECTION BP
0.6MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02432196 · ended Apr 16, 2024 · Demand increase for the drug.
ResolvedATROPINE INJECTION BP
0.4MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02432188 · ended Apr 15, 2024 · Demand increase for the drug.
ResolvedMINIMS ATROPINE SULPHATE
1% · DROPS · BAUSCH & LOMB INC
DIN 02148358 · ended Jan 30, 2024 · Shortage of an inactive ingredient or component.
ResolvedALCON ATROPINE
1% · SOLUTION · ALCON CANADA INC
DIN 00035017 · ended Sep 24, 2023 · Requirements related to complying with good manufacturing practices.
ResolvedATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Feb 3, 2023 · Disruption of the manufacture of the drug.
ResolvedATROPINE SULFATE INJECTION USP
1MG · SOLUTION · PFIZER CANADA ULC
DIN 00328154 · ended Aug 10, 2022 · Demand increase for the drug.
ResolvedATROPINE SULFATE INJECTION USP
.6MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 00392693 · ended Jul 13, 2022 · Demand increase for the drug.
ResolvedATROPINE SULFATE INJECTION
1MG · SOLUTION · LABORATOIRE AGUETTANT
DIN 02426277 · ended Jun 8, 2022 · Demand increase for the drug.
Showing 12 of 31 reports. All reports are on file with Health Canada.
What's happening
Atropine is currently affected by an active shortage report filed with Health Canada by PHARMA STULLN INC..
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Atropine is classified under “BELLADONNAAND DERIVATIVES, PLAIN” (ATC A03BA).
Recent changes
Common questions
When will Atropine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Atropine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All belladonnaand derivatives, plain shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.